174 related articles for article (PubMed ID: 17878100)
1. [Radioimmunotherapy of follicular lymphoma: a step towards cure?].
Ketterer N; Bischof Delaloye A; Helg C; Luthi F; Buchegger F
Bull Cancer; 2007 Sep; 94(9):799-806. PubMed ID: 17878100
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.
Buchegger F; Press OW; Delaloye AB; Ketterer N
Oncologist; 2008 Jun; 13(6):657-67. PubMed ID: 18586921
[TBL] [Abstract][Full Text] [Related]
3. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
DeNardo GL
Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
[TBL] [Abstract][Full Text] [Related]
4. Dose intensified molecular targeted radiotherapy for cancer-lymphoma as a paradigm.
DeNardo G; DeNardo S
Semin Nucl Med; 2010 Mar; 40(2):136-44. PubMed ID: 20113681
[TBL] [Abstract][Full Text] [Related]
5. Current status and perspective of antibody therapy in follicular lymphoma.
Buske C; Weigert O; Dreyling M; Unterhalt M; Hiddemann W
Haematologica; 2006 Jan; 91(1):104-12. PubMed ID: 16434378
[TBL] [Abstract][Full Text] [Related]
6. Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma--role of radioimmunotherapy.
Dreyling M; Trümper L; von Schilling C; Rummel M; Holtkamp U; Waldmann A; Wehmeyer J; Freund M
Ann Hematol; 2007 Feb; 86(2):81-7. PubMed ID: 17068667
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy in follicular lymphoma.
Illidge T; Morschhauser F
Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
[TBL] [Abstract][Full Text] [Related]
9. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
Sautter-Bihl ML; Bihl H
Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
[TBL] [Abstract][Full Text] [Related]
11. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibody therapy for malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
[TBL] [Abstract][Full Text] [Related]
13. First-line treatment of follicular lymphoma in the era of monoclonal antibodies.
Coiffier B
Clin Adv Hematol Oncol; 2005 Jun; 3(6):484-91, 505. PubMed ID: 16167027
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for follicular lymphoma.
Maloney DG
Curr Hematol Rep; 2003 Jan; 2(1):13-22. PubMed ID: 12901150
[TBL] [Abstract][Full Text] [Related]
15. Current management of follicular lymphomas.
Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
[TBL] [Abstract][Full Text] [Related]
16. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
Leonard JP; Coleman M; Kostakoglu L; Chadburn A; Cesarman E; Furman RR; Schuster MW; Niesvizky R; Muss D; Fiore J; Kroll S; Tidmarsh G; Vallabhajosula S; Goldsmith SJ
J Clin Oncol; 2005 Aug; 23(24):5696-704. PubMed ID: 16110029
[TBL] [Abstract][Full Text] [Related]
17. Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.
Turturro F
Expert Rev Anticancer Ther; 2007 Jul; 7(7):959-65. PubMed ID: 17627454
[TBL] [Abstract][Full Text] [Related]
18. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
Sun LQ; Vogel CA; Mirimanoff RO; Coucke P; Slosman DO; Mach JP; Buchegger F
Cancer Res; 1997 Apr; 57(7):1312-9. PubMed ID: 9102219
[TBL] [Abstract][Full Text] [Related]
19. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
Gregory SA; Hohloch K; Gisselbrecht C; Tobinai K; Dreyling M
Oncologist; 2009; 14 Suppl 2():4-16. PubMed ID: 19819920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]